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ABSTRACT
Toxin–antitoxin systems (TAs) are ubiquitous among bacteria and play a crucial role in the dissemination and evolution of
antibiotic resistance, such as maintaining multi-resistant plasmids and inducing persistence formation. Generally, activities
of the toxins are neutralised by their conjugate antitoxins. In contrast, antitoxins are more liable to degrade under specific
conditions such as stress, and free active toxins interfere with essential cellular processes including replication, translation
and cell-wall synthesis. TAs have also been shown to be responsible for plasmid maintenance, stress management,
bacterial persistence and biofilm formation. We discuss here the recent findings of these multifaceted TAs (type I–VI) and in
particular examine the role of TAs in augmenting the dissemination and maintenance of multi-drug resistance in bacteria.
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INTRODUCTION
Antibiotic resistance has been highlighted as one of the
most pressing concern of 21th century. The rapid spread of
‘superbugs’, including Enterobacteriaceae with NDM-1 (New
Delhi Metallo-beta-lactamase-1), KPC-2 (Klebsiella pneumoniae
carbapenemase-2) and the most recent reported MCR-1 (mobile
colistin resistance-1), has been described as a global crisis and
an impending return to the pre-antibiotics era (Moellering 2010;
Liu et al. 2015). To rationally combat antibiotic resistance, we
require a better understanding of which factors influence the
emergence and persistence of antibiotic resistant clones. Bacte-
rial toxin–antitoxin systems (TAs), originally linked to plasmid
maintenance systems (Ogura and Hiraga 1983), exert important
activities in the context of bacterial resistance and persistence
formation (Wen et al. 2014; Harms, Maisonneuve and Gerdes
2016; Patel 2016). TAs are small modules consisting of a stable
toxin and its unstable cognate antitoxin. Antitoxins are more
labile than toxins and readily degraded under stress conditions;
this allow the toxins to exert their detrimental effects, promot-
ing plasmid maintenance, slow growth and dormancy, which
is rather linked with chromosomally encoded TAs (Page and
Peti 2016). TAs are not essential for normal cell growth but are
nonetheless widely present on bacterial plasmids and chromo-
somes. It has been hypothesised that TAs play a central role that
is advantageous for cell survival in their natural habitat, such
as switching into a dormant, drug-resistance state to withstand
high levels of antibiotic stress (Page and Peti 2016). The toxins
inhibit cell growth by targeting a variety of important cellular
processes, includingDNA replication, transcription and cell-wall
Received: 29 November 2016
C© FEMS 2017. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/
licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
343
344 FEMS Microbiology Reviews, 2017, Vol. 41, No. 3
Table 1. The intracellular targets of TAs.
Targets of toxin TA groups Examples Toxin Antitoxin Cellular process inhibited
Inner cell membranes type I,V hok-sok, tisB-istR, ghoTS TisB, Hok, GhoT TisA, Sok, GhoS Cell membranes damage
Replication by DNA gyrase type II ccdAB, parDE CcdB, ParE CcdA, ParD DNA replication
tRNAfMet type II vapBC VapC VapB Translation
Ribosome-independent mRNA interferase type II mazEF MazF MazE Translation
Ribosome-dependent mRNA interferase type II relBE, higBA RelB, HigB RelE, HigA Translation
GltX:tRNA type II hipBA HipA HipB Translation
Elongation factor EF-Tu type II phd-doc Doc Phd Translation
Peptidoglycan precursors: UNAG type II ω-ε-ζ , pezTA ζ , PezT ε, PezA Cell wall synthesis
Biofilm formation type II,V mqsRA, ghoST MqsR, GhoT MqsA, GhoS Biofilm formation
mRNAs type III toxIN,cptTN, tenpIN ToxN,CptN, TenpN ToxI,CptI, TenpI Growth arrest
Cytoskeletal protein MreB and FtsA type IV yeeU-cbtA CbtA YeeU Cell morphology
Beta sliding clamp, protein DnaN type VI socAB SocB SocA DNA elongation
synthesis, which are similar to antibiotic activities (Davies and
Davies 2010; Chan, Balsa and Espinosa 2015). Because of their
ubiquity and crucial intracellular targets, the study of bacterial
toxins will help us understand their role in the dissemination
and evolution of bacterial antibiotic resistance. In this review,
we will provide a synopsis of TAs and in particular examine the
role of type II TAs in augmenting the dissemination and main-
tenance of multidrug resistance in Gram-negative bacteria.
TAs CLASSIFICATION
TAs are small genetic modules found on bacterial mobile ge-
netic scaffolds like plasmids, as well as on bacterial chro-
mosomes. The TA loci encode two-component systems that
consist of a stable toxin whose overexpression either kills the
bacterial cell or negates cell growth, and an unstable cognate
antitoxin. As a result, when a plasmid encoding the TA is lost
from a cell, the toxin is released from the existing TA complex
and kills plasmid-free cells. In essence, this is an elegant model
for perpetuating plasmid maintenance in bacterial population
(Gerdes, Rasmussen and Molin 1986). This unique system is also
called post-segregational killing. The first TA (ccdAB) identified
was carried on a F-plasmid and was shown to play an important
role in plasmid maintenance by coupling host cell division to
plasmid proliferation (Ogura and Hiraga 1983). Since this initial
discovery, a number of different TAs have been identified that
are encoded on bacterial genomes. Based on their proteomic na-
ture of their corresponding antitoxin, TAs are currently divided
into six distinct classes (Table 1).
Type I TAs
All type I toxins are small hydrophobic proteins of approxi-
mately 60 amino acid and their gene expression is regulated by
an antisense RNA transcribed from the toxin gene but in reverse
orientation (Gerdes and Wagner 2007). Type I TAs are arranged
either as overlapping, convergent transcribed genes pairs or as
divergently transcribed gene pairs located apart. In the first case,
the antitoxin is a cis-encoded antisense RNA (e.g. hok-sok, bsrG-
SR4); in the latter case, it is a trans-encoded sRNA (e.g. tisB-IstR1,
shoB-ohsC) (Brantl 2012). The first and best studied type I system
is hok-sok (host killing, hok, and suppressor of killing, sok), which
was first discovered on plasmid R1 from Escherichia coli (Gerdes,
Rasmussen and Molin 1986; Thisted and Gerdes 1992). Later,
other type I TAs were found in E. coli such as ldr-rdl, tisB-istR1,
ibs-sib, shoB-ohsC and symER (Fozo 2012; Kawano 2012; Wagner
and Unoson 2012).
All the toxins of type I TAs have an identical secondary struc-
ture consisting of one α-helical structure and are predicted to
be localised in the inner membrane, and thus to induce pores
into the bacterial cell membranes, resulting in inhibition of ATP
synthesis (Fozo, Hemm and Storz 2008). Consequently, replica-
tion, transcription and translation maybe inhibited, leading to
cellular death (Unoson andWagner 2008). For instance, TisB pro-
duces clusters of narrow anion-selective pores in lipid bilayers
that significantly disturbs the cytoplasmic membrane (Wagner
and Unoson 2012). Many toxins are not bacteriocidal, but inter-
fere with phage propagation, modulate the cell membrane or
preventmature particle formation, and in some cases, only over-
expression of toxin genes shows a toxic effect (Yamaguchi and
Inouye 2011).
Type II TAs
Type II TAs have been most extensively studied among all TAs,
and the huge number of type II TAs varies greatly from dif-
ferent bacterial species, even among the same species. Hith-
erto, 12 subgroups of type II TAs have been identified based
on toxin amino sequence homology (Leplae et al. 2011), includ-
ing mazEF (Aizenman, Engelberg-Kulka and Glaser 1996), relEB
(Takagi et al. 2005), yefM-yoeB (Kamada and Hanaoka 2005), ω-ε-ζ
(Zielenkiewicz andCeglowski 2005) andmqsRA (Gonzalez Barrios
et al. 2005; Brown et al. 2009). In type II systems, the antitoxin
is a small, unstable protein that sequesters the toxin through
protein complex formation. The expression of the two genes is
regulated at the level of transcription by the TA complex that
involves binding palindromic sequence at the promoter region.
Therefore, as the concentration of the TA complex in the cell
is reduced as a result of antitoxin degradation, the TA operon
expression is suppressed to produce more toxin and antitoxin,
and thus the type II system is also termed the ‘addiction mod-
ule’ (Yarmolinsky 1995). In most cases, the antitoxin genes are
located upstream of their cognate toxin genes so that the an-
titoxins appear to have an advantage for their production over
their cognate toxins. Conversely, there are many exceptions of
this genetic arrangement, such as higBA inwhich the toxin genes
higB is located upstream of its cognate antitoxin genes, higB
(Yamaguchi, Park and Inouye 2009; Christensen-Dalsgaard,
Jørgensen and Gerdes 2010).
Type III TAs
The toxINPa was first identified on a plasmid from Erwinia caro-
tovora subspecies atrosepticum (Pectobacterium atrosepticum) as
an example of the novel type III protein–RNA TAs (Fineran
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et al. 2009). The toxINPa locus consists of a toxin ToxNPa inhibit-
ing bacterial growth and RNA antisense ToxIPa counteracting
the toxicity. The arrangements of type III TAs are unusual, as
a toxin gene is preceded by a short palindromic repeat, which
separates the toxin from its small RNA antitoxin, composed of
several repeats of short nucleotide sequences. The short palin-
dromic repeat acts as a transcriptional terminator, regulating
the relative levels of antitoxin and toxin transcript. For exam-
ple, toxINBt located on pAW63 from Bacillus thuringiensis encodes
a toxic protein ToxNBt and a antitoxin ToxIBt containing 2.9 tan-
dem repeats of a 34-nucleotide sequence (Short, Monson and
Salmond 2015; Goeders et al. 2016). Currently, type III TAs are
divided into three subgroups sharing the same genetic organisa-
tion, namely toxIN, cptIN (for Coprococcus type III inhibitor-toxiN)
and tenpIN (for type III ENdogenous to Photorhabdus inhibitor-
toxiN) (Blower et al. 2012; Goeders et al. 2016). Though these
subgroups were identified by shared identity with ToxN, their
cognates diverge between and within the subtypes, such as
the number of repeats and the length of repeats (Blower et al.
2012; Goeders et al. 2016). All type III toxins discovered so far
serve as endoRNase that cleave mRNAs in adenine-rich regions,
whose activities inhibit by forming RNA pseudoknot–toxin
complex.
Type IV TAs
The yeeU-cbtA has been proposed for the new type IV TAs in
which the protein antitoxin interferes with binding of the toxin
to its target rather than inhibiting the toxin via direct TA bind-
ing (Masuda et al. 2012). Unlike most toxins targeting the macro-
molecular biosynthesis, CbtA is the first toxin of the TAs that af-
fects cellular morphology (Tan, Awano and Inouye 2011). CbtA
binds and inhibits the polymerisation of bacterial cytoskele-
tal proteins, MreB and FtsZ. The antitoxin, YeeU, suppresses
the CbtA toxicity by stabilising the CbtA target proteins rather
than by directly interacting with CbtA to suppress its toxicity
(Masuda et al. 2012). Specifically, YeeU directly binds to both
MreB and FtsZ and enhances the bundling of their filaments in
vitro. Notably, this is a unique feature of the yeeU-cbtA system,
distinguishing it from all the other TAs in that CbtA and YeeU
does not form a complex. Nevertheless, YeeU is able to neu-
tralise CbtA toxicity. Thus, the yeeU-cbtA constitutes a new type
of TA.
Type V TAs
The ghoTS is a new type of TA, where GhoS (ghost cell sup-
pressor) is the first known antitoxin to neutralise the toxic-
ity of GhoT ghost cell toxin, by specifically cleaving its mRNA
(Wang et al. 2012). Compared to the high overlapping cat-
alytic sites of CRISPR-associated-2 protein SSO1404 structures,
Wang et al. (2012) suggested that the antitoxin, GhoS, is a
sequence-specific endoRNase that cleaves ghoT transcription
and thereby prevents GhoT translation. GhoT is a membrane-
damaging protein, and its production can lyse the cell mem-
brane and change its morphologies. Ultimately, this causes the
formation of ghost cells, a group of dead or dying cells in
which cell outline is still visible but the cytoplasmic area is
transparent (Wang et al. 2012). GhoT has also been shown to
contribute to biofilm formation—after the deletion of its re-
pressor GhoS, the formation of biofilm and cell motility in-
creased by approximately 6- and 2-fold, respectively (Wang
et al. 2012).
Type VI TAs
In contrast to typical TAs, in which toxicity of the toxin is neu-
tralised by the antitoxin, socB is unique and constitutively con-
trolled by the protease CIpXP, while its cognate socA acts as a
proteolytic adaptor, promoting the degradation of SocB by CIpXP.
SocB identified in Caulobacter crescentus has been proposed to
inhibit DNA replication through direct interaction with DnaN,
a ring-shaped protein that encodes a central component for
DNA elongation (Markovski and Wickner 2013). This interaction
disrupts the association of DnaN and Pol III and other DnaN-
binding proteins, resulting in the collapse of the DNA replication
forks. It also has been shown that this DNA damage can cause
the accumulation of SocB, suggesting that it may play a regula-
tory role in the induction of the RecA-mediated SOS response
(Aakre et al. 2013; Markovski and Wickner 2013; Page and Peti
2016). Therefore, the socA-socB systemmay play important roles
in promoting Caulobacter adaptation to varying environmental
conditions by preventing DNA replication.
THE CELLULAR TARGETS OF TAs
In last decade, an increasing number of cellular targets for TAs
have been elucidated, and most of them are involved in many
essential bacterial processes such as DNA replication, RNA tran-
scription and protein translational modification as shown in
Table 1 and Fig. 1. Interestingly, TAs share many cellular targets
with that of the antibiotics. For instance, zeta toxin phosphory-
lates the essential nucleotide sugar UDP-N-acetylglucosamine
(UNAG), and leads to the inhibition of cell-wall synthesis, much
like the activity of penicillin, that inhibits the formation of pep-
tidoglycan across-links in the bacterial cell wall or glycopep-
tides that bind cell-wall precursors (Kohanski, Dwyer andCollins
2010). Another example are DNA gyrases that can induce and
relax supercoils during DNA replication yet are the target of
toxins CcdB and ParE, as well as quinolone antibiotics that
disrupt DNA replication by binding to DNA-gyrase complexes
(Kohanski, Dwyer and Collins 2010). Due to their remarkable
similarity in cellular targets between TAs and antibiotics, TAs
may provide novel insights into the discovery and development
of new antimicrobials.
Targeting cell-wall synthesis: Zeta toxin
The epsilon zetas were originally discovered as plasmid main-
tenance modules on a 29-kb low-copy plasmid, pSM19035, iso-
lated from Streptococcus pyogenes (Zielenkiewicz and Ceglowski
2005). pSM19035 stability is conferred by two regions (segA and
segB), and their corresponding products, SegA and SegB, con-
trol the plasmid partitioning (Ceglowski et al. 1993; Ana et al.
2000). The segB gene complex consists of four genes (δ and ω-
ε-ζ ), ensuring a ‘better-than-random’ plasmid segregation. The
gene δ shares a significant homology to ATPases involved in ac-
tive plasmid partitioning, but stabilisation function is depen-
dent on the ω-ε-ζ operon. Therefore, among TAs, the organisa-
tion of the ω-ε-ζ operon is unique. The first three-component
operon with the ε and ζ genes encodes an antitoxin and toxin,
respectively, and the transcription of this operon is controlled
by the additional gene ω (Ana et al. 2000; Zielenkiewicz and
Ceglowski 2005). It has been show that the product of ω binds to
the promoter of the entire operon as a dimer, and in the absence
of ω repression, the intensity of transcription from ω is increased
about 40-fold (Ana et al. 2000). Plasmid-encoded epsilon-zeta
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Figure 1. The intracellular targets of TAloci. TA loci usually encode two genes: one is a stable toxin and the other one is an unstable antitoxin. The antitoxins sequester
the toxins but are subjected to proteolytic degradation by cellular proteases (Lon or ClpXP) under stress condition. Consequently, free active toxins alter cellular
processes including DNA replication, translation or cell-wall synthesis, which ultimately results in slow growth or the formation of highly drug-tolerant persisters.
TAs examples for the cellular targets are given below. (1) Zeta toxin inhibits cell-wall synthesis by specific phosphorylation of peptidoglycan precursor UNAG. (2) TisB,
HokB and GhoT: the products of TisB and HokB can decrease the level of membrane potential motive force (pmf) and ATP by inserting into cytoplasmic membrane,
while protein GhoT can lyse cell membrane and change cell morphologies. (3) CcdB and ParE inhibit DNA replication by poison DNA gyrase. (4) Doc inhibits translation
by phosphoralation of elongation factor Tu (EF-Tu). (5–7) MazF, RelB and VapC inhibit translation by cleavage of mRNAs like single-stranded mRNA, A-site on ribosome
and initiator tRNAfMet, respectively. (8) HipA inhibits translation by phosphoration of GltX. tRNA:fMet indicates initiator tRNA at P site carried formyl methionine; ‘p’
indicates phosphorylation.
TAs enhance plasmid maintenance by killing the plasmid-free
daughter cells (Zielenkiewicz and Ceglowski 2005), whereas
chromosomally encoded epsilon-zeta TA family (pezAT for pneu-
mococcal epsilon-zeta) identified from S. pneumoniae kills bacte-
ria through the inhibition of cell-wall synthesis. More recently,
Mutschler and Meinhart (2011) showed that toxin PezT inhibits
the bacteria cell-wall synthesis by phosphorylating the UNAG
into a toxicmodule UNAG-3-phosphate (UNAG-3P). UNAG-3P ac-
cumulates and competitively inhibits MurA, which is the essen-
tial enzyme for peptidoglycan synthesis (Barreteau et al. 2008),
thereby freeing PezT toxin that poisons bacteria through in-
hibition of the cell-wall formation, causing the cells to lyse
(Mutschler and Meinhart 2011; Mutschler et al. 2011).
The zeta toxin systems have been identified as highly
abundant modules in multi-resistance plasmids and chromo-
somes of various Gram-positive pathogens, including S. pyogenes
(Zielenkiewicz and Ceglowski 2005) and S. pneumoniae (Khoo
et al. 2007). It has long been thought that epsilon-zeta systems
only can be found in Gram-positive bacteria; however, a novel
zeta homolog has been first identified from the Gram-negative
bacterium Escherichia coli (Rocker and Meinhart 2015). This zeta
toxin, designated EzeT for E. coli zeta toxin, is located in 3.4-kb
islet, consisting of two domains featuring EzeT toxin and
epsilon-like antitoxin within a single polypeptide chain. Similar
to the toxin PzeT, the C-terminal domain of EzeT containing all
catalytic motifs of UNAG kinases is capable of phosphorylating
UNAG in vitro (Mutschler et al. 2011; Rocker and Meinhart 2015).
In contrast to conventional type II TAs, N-terminal domain of
EzeT contains an antitoxin; thus, EzeT is an authentic zeta-like
UNAG kinase and is also the first auto-inhibited TA system, since
it can be inhibited by its own N-terminal cis-acting antitoxin do-
main (Rocker and Meinhart 2015).
Targeting tRNAs: VapC and HipA
PIN (N-terminus of the pilin biogenesis protein PiIT) domains
are small protein domains consisting of 130 amino acid in
length, and serve as ribonuclease enzymes that cleave single-
stranded RNA in a sequence-dependent manner (Arcus et al.
2011). The TA module vapBC (virulence-associated protein) is
associated with PIN-domain proteins. The vapBC (at that time
called vagCD) locus derived from virulence plasmid of Salmonella
Dublin strain G19 was proposed to prevent plasmid loss under
nutrient-limiting conditions (Pullinger and Lax 1992). VapC is the
PIN-domain ribonuclease, co-expressed with cognate inhibitor
VapB that forms a novel PIN-domain–inhibitor complex (Bunker
et al. 2008; Arcus et al. 2011). vapBC are surprisingly abundant;
for example, the genome of Mycobacterium tuberculosis encodes
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Figure 2. Model of the TisB toxin induced SOS response and persistence formation. (1) Antibiotics (like ciprofloxacin) kill bacteria by damaging their DNA; (2) the SOS
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47 different vapBC homologs (Ahidjo et al. 2011). The transcrip-
tion of vapBC operon is regulated by the DNA promoter, via the
N-terminal ribbon-helix-helix domain of antitoxin VapB. The
proteolytic degradation of the more labile VapB by Lon protease
results in the accumulated level of VapC toxin. Once activated,
VapC inhibits mRNA transcription presumably by site-specific
cleavage of tRNAfMet, which plays a crucial role in the protein
synthesis of bacteria (Bunker et al. 2008; Winther and Gerdes
2012). HipA function acts in similar manner to VapC, but has
different binding sites. In contrast to phosphorylate EF-Tu, free
HipA inactivates GltX by phosphorylation at its ATP-binding site
Ser239, and thus GltX is unable to charge tRNA with glutamate
(tRNAGlu). Consequently, this induces amino acid starvation and
the invariable activation of RelA to more (p)ppGpp synthesis.
Thus, high accumulated levels of (p)ppGpp trigger a stringent
response that inhibits the global translation process such as pro-
tein synthesis (Kaspy et al. 2013; Germain et al. 2015).
Targeting DNA gyrase: CcdB and ParE
The ccd (couple cell division) locus is adjacent to the origin of
replication of the F plasmid and promotes the stable mainte-
nance of F plasmids by coupling host cell division to plasmid
proliferation (Ogura and Hiraga 1983). The target of toxin ccdB,
DNA gyrase, is a ubiquitous bacterial enzyme essential for neg-
ative supercoiling of DNA during DNA replication and transcrip-
tion (Dao-Thi et al. 2005; No¨llmann, Crisona andArimondo 2007).
Gyrase is known to consist of two subunits (GyrA and GyrB),
GyrA contains a catalytic domain for DNA binding and cleav-
age, and GyrB contains the ATPase domain. Quinolones are able
to inhibit the topoisomerase ligase domain by forming a DNA-
topoisomerase-quinolone complex to block DNA and RNA poly-
merases (Wentzell and Maxwell 2000). The bacterial toxins ccdB
and parE present similar properties to those of quinolones, but
interact at a different site to DNA gyrase (Jiang et al. 2002; Dao-
Thi et al. 2005). Under normal growth conditions, the antitoxin
CcdA inhibits CcdA toxic activity by forming a tight CcdA2–
(CcdB)2 complex. Once the bacterium loses its plasmid, unstable
CcdA degrades and CcdB and GyrA form a symmetric complex.
After CcdB-GyrA binding, ATP is hydrolysed and the supercoiled
DNA is released resulting in blocking bacterial transcription and
immediate cell death (Critchlow et al. 1997; Dao-Thi et al. 2005).
More recently, an additional role for CcdB has been that of a per-
sistence factor (Tripathi et al. 2012). When faced with antibiotic
or heat stress, the increased levels of the ATP-dependent pro-
tease Lon (Kuroda et al. 2001), responsible for the rapid turnover
of unstable proteins, degrade the antitoxin CcdA, freeing toxin
CcdB. Free active toxin CcdB causes DNA damage through form-
ing a GyrA-CcdB cleavage complex, which triggers the RecA-
mediated SOS response. Ultimately,multidrug-tolerant persister
cells are formed.
Targeting membrane potential: HokB and TisB
tisB/istR-1 is the first TA locus involved in the SOS response. The
locus encodes two small RNA molecules: one is an antisense
RNA, istR-1, that inhibits TisB toxicity, and the toxin, TisB, un-
der the control of Lex (Vogel et al. 2004; Darfeuille et al. 2007)
and is localised on the inner membrane (Unoson and Wagner
2008) (Fig. 2). The induction of tisB results in membrane damage
that entails a rapid decrease in DNA replication, RNA transcrip-
tion and protein synthesis (Unoson and Wagner 2008). HokB is
similar to TisB in that both are small proteins, and exert toxic-
ity by damaging the inner membrane. The hokB-sokB locus de-
rived from chromosome of E. coli K-12 codes for three genes:
sokB, mokB and hokB (Pedersen and Gerdes 1999). The sokB is a
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small antisense RNA that controls the translation of the mokB
reading frame. hokB translation is under the control of mokB,
thereby sokB can also suppress hokB toxicity. Recent studies
have shown that HokB acts as a potential persistence factor
(Verstraeten et al. 2015) and its accumulated leads to a loss
of membrane electrochemical potential, ultimately resulting in
persistence.
Targeting ribosomes: Doc, MazF and RelE
The toxin doc (death on cure) and its conjugate antidote, phd
(prevent host death), are derived from the bacteriophage P1 and
play a major role in plasmid stability persistence, programmed
cell death and stress response (Lehnherr et al. 1993; Gazit and
Sauer 1999). Doc has been showed to be a representative mem-
ber of the Fic protein subfamily, which is ubiquitous in bacteria
and involved in crucial functions (such as bacterial pathogen-
esis) (Garcia-Pino et al. 2008; Harms, Maisonneuve and Gerdes
2016). Fic proteins have a central conserved HXFX(D/E)N(K/G)R
motif that is present in Doc structures. Phd dimers are subject
to cleavage by CIpXP protease, an ATP-dependent protease of E.
coli (Lehnherr and Yarmolinsky 1995). It has been shown that
mRNA is significantly stabilised upon Doc induction, suggesting
that Doc does not cleave mRNA. In fact, Doc toxicity has been
proposed to act in a similar manner to hygromycin B (HygB), an
aminoglycoside antibiotic (Liu et al. 2008). After degradation of
Phd by CIpXP protease, the free Doc binds on the 30S riboso-
mal subunit that includes the HygB-binding site and phospho-
rylates the conserved threonine (Thr382) of the elongation fac-
tor EF-Tu. Subsequently, Doc-bound EF-Tu is unable to bind to
aminoacylated tRNAs which leads to an accumulation of stalled
ribosomes, blocking protein synthesis, and thus a dormant state
is formed (Liu et al. 2008; Castro-Roa et al. 2013). The MazF and
RelE proteins are also RNases, which inhibit translation by the
cleavage of mRNA. Purified MazF is a sequence-specific (ACA)
endoribonuclease, which only cleaves single-stranded mRNA at
VUUV’ sites independently of the ribosomes, by a mechanism
very similar to that of E. coli RelE (Christensen et al. 2003; Zhang
et al. 2003; Donegan andCheung 2009). In the context of the strin-
gent response, antitoxin RelB is degraded byATP-dependent pro-
tease Lon, which leads to activate RelE. The activated RelE in-
duces a global inhibition of translation by cleavage of the mRNA
at the ribosome A-site, with the consequence of the tRNA degra-
dation (Christensen and Gerdes 2003; Pedersen et al. 2003). Con-
sequently, this activates RelE to trigger a stringent response, cre-
ating high-tolerant persisters.
Targeting bacterial biofilm formation: MqsR
Bacterial biofilms are communities in which cells aggregate on
a solid surface and are further enveloped in an exopolysaccha-
ride matrix (Mah and O’Toole 2001; Stewart and Costerton 2001).
It has been shown that biofilms are closely linked to antibiotic
resistance and that a biofilm can form slimy layers that sur-
round the bacteria and act as a barrier to antimicrobial agents,
decreasing the penetration of antibiotics to the bacterium’s sur-
face (Davies 2003). When cells are embedded in a biofilm, their
MIC has been shown to increase from 6.25 to >400 μg/ml de-
pending on the antimicrobial agent (Evans and Holmes 1987).
Besides failure of antibiotic diffusion, some studies have demon-
strated that biofilm-associatedmultidrug-resistant Pseudomonas
aeruginosa cells can cause slow growth, lipopolysaccharidemod-
ification and antibiotic degradation, ultimately accompanied by
an increase in antibiotic resistance (de la Fuente-Nu´n˜ez et al.
2013). The first TAs shown to be involved in biofilm formation
was mqsRA(motility quorum-sensing regulator), a typical type II
TAs in which the toxicity of protein MqsR is neutralised by its
conjugate antitoxin MqsA (Gonzalez Barrios et al. 2005; Brown
et al. 2009; Wang and Wood 2011). Gonzalez Barrios et al. (2005)
demonstrated that toxin MqsR is significantly stimulated by
biofilm formation and enhanced cell motility. It has been sug-
gested that MqsR is an RNase and prevents translation by cleav-
ing RNAs (Brown et al. 2009). In addition, antitoxin MqsA has
been linked to the regulation of the general stress responses,
such as oxidative stress (Wang et al. 2011). Wang et al. confirmed
that MqsA represses the stress regulator, RpoS, leading to the
decreased concentration of messenger 3,5-cyclic diguanylic acid
and thus decreasing biofilm formation. However, upon stress,
for example, oxidative stress, MsqA is unstable and is rapidly
degraded by Lon and ClpXP protease, causing the accumulation
of RpoS. As a result, the stringent response is triggered, and the
bacterial state is switched fromhighmotility (planktonic) to ses-
sile (biofilm) state.
BIOLOGICAL ROLE OF TAs IN ANTIMICROBIAL
RESISTANCE
Initially, TAs were identified on plasmids and used to be con-
sidered as selfish genes with little or no physiological benefit to
the host cells. Because if a plasmid encoding the TAs is absent
in the daughter cell, the stable toxin is released by rapidly de-
grading antitoxin to kill plasmid-free cells, in order to increase
plasmidmaintenance in host cells. Since their discovery, the role
of TAs has been debated over decades. Hitherto, mounting evi-
dence has testified that TAs are far more than selfish loci and
that they play key roles in promoting cell survival. In particu-
lar, in response to antibiotic stress, toxins can be activated by
stress-induced protease like CIpXP and Lon. This phenomenon
results in slow cellular growth in which the bacterium can now
effectively tolerate antibiotic challenge.
THE MAINTENANCE OF MULTIDRUG
RESISTANCE PLASMIDS
Conjugative plasmids identified as reservoirs for resistance
genes are one of the most effective physical forums to develop
and disseminate the antibiotic resistance genes among bacte-
ria (Carattoli 2013; Mathers, Peirano and Pitout 2015). In many
cases, plasmids can carry genes that are highly beneficial to
the host bacteria by enabling them to persist in unfavourable
environments, e.g. protection against potentially lethal antibi-
otics. Therefore, plasmids serve as effective DNA shuttles for
antibiotic resistance genes that are, in part, linked to the clin-
ical failure of antibiotics treatments. However, because plas-
mids are extrachromosomal,mobile genetic elements presented
in host cells, plasmids impose a metabolic burden to the host
cells, which are prone to elimination from bacterial genome in
the absence of selective pressure (Zielenkiewicz and Ceglowski
2001). The stable inheritance of plasmids is achieved by acti-
vating the plasmid-specified partitioning proteins into dividing
cells and selective killing of the cells that failed to acquire a
plasmid (Hayes 2003). As discussed above, TAs, like hok-sok and
ccdAB, are responsible for the plasmids stabilisation; thus, TAs
also have been viewed as ‘addiction modules’ (Engelberg-Kulka
et al. 2006). Beside plasmids, TAs appear to play a stabilising role
in genomic islands, for instance, SXT, an integrative and con-
jugative element that mediates tolerance to multiple antibiotics
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in Vibrio cholera (Wozniak and Waldor 2009). One novel TA pair
(designated mosAT) within SXT has been identified to promote
SXT stability. Ectopic expression of mosT causes growth inhibi-
tion and MosA can neutralise the toxic effect of overexpressed
MosT. Similar to plasmid-borne toxins, when SXT is vulnera-
ble to loss, MosT expression is activated to minimise the SXT-
free cells. Therefore, the activity of mosAT may contribute to
the maintenance of SXT in bacterial populations (Wozniak and
Waldor 2009).
BACTERIAL STRESS RESPONSE
The SOS response is important for bacterial survival under stress
conditions that can trigger disruption of the DNA replication
fork and result in the accumulation of single-stranded DNA.
Both RecA and LexA proteins have an important role in the SOS
response as regulators (Yamaguchi and Inouye 2011). RecA, ac-
tivated by single-strand DNA, is involved in the inactivation of
the repressor LexA. Normally, LexA binds to a specific sequence
in the DNA (the SOS box) and represses the expression of genes
involved in DNA repair, mutagenesis and cell growth arrest. The
SOS response is an important factor for persister formation in
response to the fluoroquinolone antibiotic, ciprofloxacin, which
can cause DNA damage (Dorr, Lewis and Vulic 2009; Lewis 2010).
The first TA locus, tisAB-istR-1, is involved in the SOS response
to DNA damage (Vogel et al. 2004). This locus encodes a toxic
gene tisAB and two small RNAs, IstR-1 and IstR-2, as shown in
Fig. 2. TisAB is under LexA control and thus activated by the
SOS response, but only TisB is responsible to the toxicity (Vogel
et al. 2004). The transcription of istR-2 is also SOS regulated and
not involved in the TisB control, whereas the antitoxin IstR-1
bindswith the LexA-independent promoter and inhibits TisB ex-
pression by inducing RNase III-dependent cleavage of tisBmRNA
(Vogel et al. 2004; Darfeuille et al. 2007). In the absence of an
SOS response, istR-1 is constitutively transcribed to inactive the
toxicity of TisAB by inducing RNase III-dependent cleavage of
tisB mRNA (Vogel et al. 2004). When DNA damage is caused by
ciprofloxacin, it activates the RecA protein leading to LexA re-
pressor cleavage, and then the SOS response is induced. The an-
titoxin IstR-1 that controls the Lex promoter is almost complete
cleaved, while the toxin TisB gradually accumulates and rapidly
binds to the cytoplasmicmembrane, leading tomembrane dam-
age, and the proton motive force (pmf) and ATP levels are de-
creased. This causes the rates of DNA, RNA and protein synthe-
sis to decrease, and the intake of drugs to the cells is blocked.
As a result, growth slows down and a multidrug-resistant per-
sister is formed (Vogel et al. 2004; Darfeuille et al. 2007; Unoson
and Wagner 2008; Dorr, Vulic and Lewis 2010) (Fig. 2).
PERSISTER CELLS
TAs can also contribute to bacteria persistence formation (Lewis
2010; Maisonneuve and Gerdes 2014; Page and Peti 2016). Per-
sistence is observed when a small subpopulation of cells sur-
vive antibiotic treatment that has efficiently killed off the rest
of the population. In contrast to resistance, persistence is a
form of antimicrobial tolerance that is not link with genetic
mutation or DNA acquisition, but rather with a spontaneous
switch of a dormant, non-dividing state. Therefore, persisters
are able to survive in the presence of antibiotics even if they
are genetically not programmed to become resistant. More im-
portantly; however, rather than causing cell death, some tox-
ins convert cells into a dormant or a semidormant state that is
resistance to antibiotics, and then revive them when environ-
mental conditions become more conducive for growth (Hayes
2003). TAs have been shown to play a major role in persister for-
mation in many model systems. An example of TAs mediating
persister states involves the intracellular metabolite, guanosine
tetraphosphate and pentaphosphate [(p)ppGpp], the main regu-
lator of the stringent response (Amato, Orman and Brynildsen
2013; Maisonneuve, Castro-Camargo and Gerdes 2013). In Es-
cherichia coli, (p)ppGpp was discovered as a alarmone to alter
cellular transcription globally by interacting with RNA poly-
merase activity directly, in response to nutrient starvation or
other stress (Dalebroux and Swanson 2012). As a consequence,
bacteria can survive even faced with limiting nutrients, suggest-
ing that the coupling accumulation of (p)ppGpp level may in-
duce growth arrest, drug tolerance and the formation of persis-
ters. It has been proposed that high levels of (p)ppGpp trigger
persistence by activation of the TA loci, resulting in translation
inhibition and growth arrest (Korch, Henderson and Hill 2003;
Maisonneuve, Castro-Camargo and Gerdes 2013; Schumacher
et al. 2015; Harms, Maisonneuve and Gerdes 2016). Contrary to
previous reports, there is growing evidence to suggest that EF-
Tu is not the target of HipA during the inactivation of trans-
lation, but HipA-mediated persistence depends stochastically
on the (p)ppGpp-TA pathway (Germain et al. 2013; Kaspy et al.
2013; Maisonneuve, Castro-Camargo and Gerdes 2013; Wen et al.
2014). Most likely, the currentmolecularmodel explaining HipA-
mediated persistence is shown in Fig. 3 (Korch, Henderson and
Hill 2003; Germain et al. 2013; Kaspy et al. 2013; Maisonneuve,
Castro-Camargo and Gerdes 2013; Germain et al. 2015). When
faced with particular stresses, bacteria rapidly swift transcrip-
tion profile to trigger the nucleotide alarmone (p)ppGpp syn-
thesis, which involved in catalytic activity of SpoT and RelA,
the two (p)ppGpp synthetases of E. coli (Dalebroux and Swanson
2012). The resulting increased (p)ppGpp levels accumulate inor-
ganic polyphosphate (PolyP) through inhibition of exopolyphos-
phatase (PPX), a phosphatase enzyme that degrades PolyP. The
accumulation of PolyP combines with Lon protease preferen-
tially to cleave the antitoxin HipB, resulting in an excess of toxin
HipA. In return, free active toxin HipA inactivates GltX by phos-
phorylation of its ATP-binding site Ser239, with the consequence
of uncharged tRNA accumulation in the cell. Consequently, the
amino acid starvation triggers the activation of RelA to more
(p)ppGpp synthesis. Thereby, the high level of (p)ppGpp accumu-
lation induces a stringent response that inhibits the synthesis
of DNA, RNAs, ribosomal proteins and membrane components,
promoting cells entry into dormant state. Conversely, a re-
cent study showed that the activation of yefM-yoeB (Christensen
et al. 2004), a well-characterised type II TAs, is not dependent on
the level inorganic PolyP and (p)ppGpp (Ramisetty et al. 2016),
and further suggested that the pathways of TAs-mediated per-
sistence formationmay be farmore complicated than previously
known.
CONCLUSION
In the last decade, antimicrobial resistance in Gram-negative
pathogens has outpaced the production of novel and even new
drugs entering the market place providing an increasing void
that is unlikely to be bridged. The drivers and maintenance of
antimicrobial resistance was hitherto thought to be antimicro-
bials themselves; however, increasingly we are becoming aware
that antimicrobial resistance is as much to do with genetic
maintenance systems, e.g. TAs, as it is to do with the pres-
ence of the drug. TAs are remarkable systems that parasitise the
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Figure 3. (p)ppGpp-hipA mediated persister pathway. In response to particular stresses, SpoT and RelA are activated to synthesise the nucleotide alarmone (p)ppGpp,
The increased (p)ppGpp levels lead to the accumulation of inoganic polyphosphate (PolyP) through inhibition of exopolyphosphatase (PPX), that the cellular enzyme
to degrades PolyP. The accumulated PolyP combines with Lon protease preferentially to cleave the antitoxin HipB, resulting in an excess of toxin HipA. In return, free
active toxin HipA inactivates GltX by phosphorylation of its ATP-binding site Ser239, with the consequence of uncharged tRNA with glutamate (tRNAGlu) accumulation
in the cell. Uncharged tRNAGlu loads at empty ribosomal sites and triggers the activation of RelA to more (p)ppGpp synthesis, promoting cells entry into dormant state.
Note that SpoT and RelA are bifunctional synthetase-hydrolase enzyme, if the stresses have been removed, they can hydrolase (p)ppGpp and bring cells to normal
growth (Dalebroux and Swanson 2012). The red box labelled with ‘?’ indicates that the link between stringent response-associated genes (including ppGpp, Lon, PolyP)
and TAs has been exploring in some TAs, such as relBE, mazEF and yefM-yeoB. It has been proved that the activation of toxin MazF and YoeB is dependent on the
Lon-mediated degradation of their cognates, antitoxins, but not on the accumulation of PolyP and ppGpp (Christensen et al. 2001, 2003; Ramisetty et al. 2016).
bacteria and hold it hostage. TAs are also extremely varied and
are a testimony to the dexterity and plasticity of genetic sys-
tems to adapt and evolve. Although yet to be fully established,
TAs are becoming increasingly numerous and more associated
with antimicrobial genes present on the same plasmid thereby
providingmaintenance of the antimicrobial resistance in the ab-
sence of the drug. Worryingly, the SOS induction triggered by
drugs such as fluoroquinolones activates TA systems such as
TisAB via LexA. The fact that fluoroquinolones are widespread
and poorly degraded implies an ever-present pressure on certain
TA systems to further be mobilised throughout bacterial popu-
lations.
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